Total Payments
$2,739
2024 Payments
$547.78
Companies
22
Transactions
157
Medicare Patients
8,029
Medicare Billing
$3.5M
Payment Breakdown by Category
Food & Beverage$2,659 (97.1%)
Education$79.92 (2.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,659 | 156 | 97.1% |
| Education | $79.92 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $714.55 | 64 | $0 (2024) |
| ABBVIE INC. | $406.26 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $274.83 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $171.47 | 6 | $0 (2023) |
| Allergan Inc. | $144.00 | 2 | $0 (2017) |
| EyePoint Pharmaceuticals US, Inc. | $130.83 | 3 | $0 (2023) |
| GLAUKOS CORPORATION | $123.89 | 1 | $0 (2022) |
| Genentech USA, Inc. | $120.20 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $108.51 | 7 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $96.08 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.78 | 32 | ABBVIE INC. ($90.38) |
| 2023 | $534.28 | 28 | ABBVIE INC. ($243.29) |
| 2022 | $477.78 | 18 | GLAUKOS CORPORATION ($123.89) |
| 2021 | $98.30 | 6 | Alimera Sciences, Inc. ($57.40) |
| 2020 | $190.68 | 6 | Alimera Sciences, Inc. ($179.60) |
| 2019 | $466.76 | 47 | Alimera Sciences, Inc. ($296.19) |
| 2018 | $110.27 | 12 | Alimera Sciences, Inc. ($50.57) |
| 2017 | $312.65 | 8 | Allergan Inc. ($144.00) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Dry eyes | ||||||
| 10/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: EYE CARE | ||||||
| 09/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Ophthalmology | ||||||
| 09/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| 08/24/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/16/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: SOLUTION/ DROPS | ||||||
| 07/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Ophthalmology | ||||||
| 06/18/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: EYE CARE | ||||||
| 06/04/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Dry eyes | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: EYE CARE | ||||||
| 05/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Ophthalmology | ||||||
| 04/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: EYE CARE | ||||||
| 03/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: EYE CARE | ||||||
| 03/29/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: OPTOMETRY | ||||||
| 03/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,256 | 15,513 | $2.7M | $1.1M |
| 2022 | 15 | 2,400 | 6,905 | $2.1M | $918,527 |
| 2021 | 15 | 1,837 | 6,598 | $1.9M | $852,733 |
| 2020 | 11 | 1,536 | 5,743 | $1.6M | $610,221 |
Total Patients
8,029
Total Services
34,759
Medicare Billing
$3.5M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 50 | 536 | $589,600 | $369,139 | 62.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 32 | 8,821 | $810,837 | $256,024 | 31.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 592 | 1,669 | $392,215 | $167,783 | 42.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 221 | 1,179 | $387,300 | $122,540 | 31.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 139 | 626 | $73,400 | $47,598 | 64.8% |
| 92134 | Imaging of retina | Office | 2023 | 326 | 1,320 | $112,200 | $46,309 | 41.3% |
| 92250 | Photography of the retina | Office | 2023 | 472 | 729 | $127,575 | $21,932 | 17.2% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 24 | 28 | $67,445 | $18,706 | 27.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 115 | 251 | $40,160 | $18,666 | 46.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 87 | 87 | $23,925 | $10,545 | 44.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 49 | 70 | $12,600 | $8,332 | 66.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 30 | $6,000 | $3,218 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 39 | $5,731 | $3,065 | 53.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 30 | 42 | $7,100 | $2,342 | 33.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,879 | $1,887 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,515 | 42.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 27 | $1,755 | $1,288 | 73.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 27 | 30 | $1,992 | $639.60 | 32.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 51 | 562 | $618,200 | $404,246 | 65.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 542 | 1,669 | $392,251 | $171,216 | 43.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 198 | 1,128 | $369,750 | $117,555 | 31.8% |
| 92134 | Imaging of retina | Office | 2022 | 332 | 1,318 | $112,045 | $46,954 | 41.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 146 | 768 | $76,800 | $41,873 | 54.5% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 130 | 130 | $87,060 | $28,014 | 32.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 130 | 130 | $86,535 | $27,844 | 32.2% |
About Dr. Jonathan Gloth, M.D
Dr. Jonathan Gloth, M.D is a Ophthalmology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932361110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Gloth, M.D has received a total of $2,739 in payments from pharmaceutical and medical device companies, with $547.78 received in 2024. These payments were reported across 157 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,659).
As a Medicare-enrolled provider, Gloth has provided services to 8,029 Medicare beneficiaries, totaling 34,759 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Toms River, NJ
- Active Since 06/27/2008
- Last Updated 05/12/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1932361110
Products in Payments
- Iluvien (Drug) $475.79
- DURYSTA (Drug) $219.77
- OZURDEX (Drug) $206.77
- ILUVIEN (Drug) $173.67
- EYLEA (Biological) $168.37
- YUTIQ (Drug) $145.35
- KXL SYSTEM (Device) $123.89
- Cequa (Drug) $108.51
- EYLEA AFLIBERCEPT INJECTION (Biological) $106.46
- OXERVATE (Drug) $69.05
- Lucentis (Biological) $67.63
- LUMIGAN (Drug) $64.73
- PROKERA (Device) $53.34
- ACTHAR (Biological) $42.98
- TOTAL30 (Device) $40.12
- Vabysmo (Drug) $37.67
- XDEMVY (Drug) $36.07
- TYRVAYA (Drug) $35.65
- Syfovre (Drug) $35.38
- BOTOX (Biological) $30.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Toms River
Dr. Vipul Lakhani, Md, MD
Ophthalmology — Payments: $9,723
Ophthalmology $9,723
Dr. Harjit Athwal, M.d, M.D
Ophthalmology — Payments: $6,988
Ophthalmology $6,988
Mr. Anil Birdi, M.d, M.D
Ophthalmology — Payments: $6,949
Ophthalmology $6,949
Dr. Barinder Athwal, M.d, M.D
Ophthalmology — Payments: $6,001
Ophthalmology $6,001
Dr. Omar Almallah, Md, MD
Ophthalmology — Payments: $5,788
Ophthalmology $5,788
Lisa Athwal
Ophthalmology — Payments: $5,533
Ophthalmology $5,533